A122310 Stock Overview
Engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Genoray Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,470.00 |
| 52 Week High | ₩7,160.00 |
| 52 Week Low | ₩5,250.00 |
| Beta | 0.63 |
| 1 Month Change | -4.70% |
| 3 Month Change | -9.59% |
| 1 Year Change | -20.84% |
| 3 Year Change | -39.69% |
| 5 Year Change | -22.41% |
| Change since IPO | -56.06% |
Recent News & Updates
Genoray's (KOSDAQ:122310) Soft Earnings Are Actually Better Than They Appear
Nov 21
Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems
Mar 28Recent updates
Genoray's (KOSDAQ:122310) Soft Earnings Are Actually Better Than They Appear
Nov 21Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems
Mar 28Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?
Apr 12Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?
Mar 01We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending
Feb 11
Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 27Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?
Jan 12Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend
Dec 24A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)
Dec 15We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt
Nov 30Shareholder Returns
| A122310 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -2.7% | -3.2% | -3.7% |
| 1Y | -20.8% | -3.0% | -10.4% |
Return vs Industry: A122310 underperformed the KR Medical Equipment industry which returned -3.1% over the past year.
Return vs Market: A122310 underperformed the KR Market which returned -10.4% over the past year.
Price Volatility
| A122310 volatility | |
|---|---|
| A122310 Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A122310 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A122310's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 346 | Byung Uk Park | www.genoray.com |
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide.
Genoray Co., Ltd. Fundamentals Summary
| A122310 fundamental statistics | |
|---|---|
| Market cap | ₩73.32b |
| Earnings (TTM) | ₩7.63b |
| Revenue (TTM) | ₩108.97b |
9.6x
P/E Ratio0.7x
P/S RatioIs A122310 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A122310 income statement (TTM) | |
|---|---|
| Revenue | ₩108.97b |
| Cost of Revenue | ₩68.12b |
| Gross Profit | ₩40.85b |
| Other Expenses | ₩33.22b |
| Earnings | ₩7.63b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 569.59 |
| Gross Margin | 37.49% |
| Net Profit Margin | 7.01% |
| Debt/Equity Ratio | 20.8% |
How did A122310 perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield28%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 12:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Genoray Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |
| Joo-won Ahn | Yuanta Securities Korea Co., Ltd. |